DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
162. 類天疱瘡(後天性表皮水疱症を含む。)
Pemphigoid
Clinical trials
/
Disease details
臨床試験数
:
90
/
薬物数
:
122
- (
DrugBank
:
47
) /
標的遺伝子数
:
34
-
標的パスウェイ数
:
144
Search
1 trial found
10
50
100
ALL
diseases per page:
Showing 1 to 1 of 1 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT05263505
(
ClinicalTrials.gov
)
February 21, 2022
16/2/2022
Baricitinib
for the Treatment of Ocular Mucous Membrane Pemphigoid
Baricitinib
for the Treatment of Ocular Mucous Membrane Pemphigoid
Mucous Membrane Pemphigoid;Cicatrizing Conjunctivitis
Drug:
Baricitinib
2 MG [Olumiant]
;Drug:
Methotrexate
;Drug:
Azathioprine
;Drug:
Mycophenolate
Washington University School of Medicine
Eli Lilly and Company
Recruiting
18 Years
N/A
All
20
Phase 2
United States